Sunshine Heart Inc  

(Public, ASX:SHC)   Watch this stock  
Find more results for SHC
- Close
ASX data delayed by 20 mins - Disclaimer
Currency in
Range     -
52 week 0.02 - 0.06
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -1.81
Shares     -
Beta     -
Inst. own     -
Mar 16, 2016
Q4 2015 Sunshine Heart Inc Earnings Release (Estimated) - 12:30AM GMT+11 - Add to calendar
Nov 20, 2015
Sunshine Heart Inc at Canaccord Genuity Medical Technology & Diagnostics Forum

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin - -8673.56%
Operating margin - -8741.35%
EBITD margin - -8647.46%
Return on average assets -81.84% -58.42%
Return on average equity -122.46% -63.22%
Employees 54 -
CDP Score - -


12988 Valley View Rd
EDEN PRAIRIE, MN 55344-3657
United States - Map
+1-952-3454200 (Phone)
+1-302-6365454 (Fax)

Website links


Sunshine Heart, Inc. is an early-stage medical device company. The Company is focused on developing, manufacturing and commercializing C-Pulse Heart Assist System (the C-Pulse System) for treatment of Class III and ambulatory Class IV heart failure. The C-Pulse System utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. The system's single unit driver and battery source are contained inside a carrying bag. The sales of the C-Pulse System have been to United States hospitals and clinics who participate in the Company's clinical studies.